ERBB2 and breast carcinoma: Previously, we showed that in the MMTV-Wnt1 and MMTV-Neu transgenic mouse models of breast cancer, in which the oncogene expression is driven by the mouse mammary tumor virus promoter (MMTV), treatment with Am580 [40] significantly prolonged tumor-free survival and impaired tumor growth [39].